Location: El Centro
Synced from ClinicalTrials.gov · August 08, 2026
Clinical studies recruiting near El Centro
Studies with at least one listed site matching this
location on the public registry. Each page explains the study in plain
language, with locations and study-team contacts.
Clinicians: generate a
printable list for your patient →
🔍 Search another city or condition
A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart Phase 3 · CON-10075 El Centro, CA Investigational Site · Colorado Prevention Center · NCT06024746 This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in Phase 3 · Pfizer · NCT06758401 A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carbop Phase 3 · Hoffmann-La Roche · NCT06793215 Evaluating the Impact of Maridebart Cafraglutide on Cardiovascular Outcomes in Participants With Atherosclerotic Cardiov Phase 3 · Amgen · NCT07037433 Coordinating Outpatient bupreNorphiNe for Emergency Care and Continuing Treatment NA · El Centro Regional Medical Center Emergency Department · University of California, Davis · NCT07024498 Efficacy of INM004 in Children With STEC-HUS Phase 3 · Inmunova S.A. · NCT06389474 EASi-KIDNEY™ (The Studies of Heart & Kidney Protection With BI 690517 in Combination With Empagliflozin) Phase 3 · Boehringer Ingelheim · NCT06531824 Feasibility Study of an Accommodating IOL Design NA · Alcon Research · NCT07147192 A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040) Phase 3 · Eli Lilly and Company · NCT06672549 A Study of Mezagitamab in Adults With Kidney Condition Called IgA Nephropathy Phase 3 · Takeda · NCT06963827 ShortStop-HER2: 12 Months vs. 6 Months of HER2-targeted Medications for People With HER2+ Breast Cancer Who Had a Pathol Phase 3 · Alliance for Clinical Trials in Oncology · NCT06876714 Pan Tumor Rollover Study Phase 2 · Bristol-Myers Squibb · NCT03899155 A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis Phase 3 · Ipsen · NCT06016842 A Phase 3 Study of NTLA-2001 in ATTRv-PN Phase 3 · Intellia Therapeutics · NCT06672237 A Clinical Study of Tulisokibart (MK-7240) to Treat Radiographic Axial Spondyloarthritis (MK-7240-013) Phase 2 · Merck Sharp & Dohme LLC · NCT07133633 A Research Study Looking at Long-term Treatment With Mim8 in People With Haemophilia A Phase 3 · Novo Nordisk A/S · NCT05685238 Efficacy and Safety of Orforglipron in Participants With Peripheral Artery Disease Phase 3 · Eli Lilly and Company · NCT07223593 EPIC-Peds: A Study to Learn About the Study Medicine Called PF-07321332 (Nirmatrelvir)/Ritonavir in Patients Under 18 Ye Phase 3 · Pfizer · NCT05261139 Intervening on Women's Health for Rural Young Cancer Survivors NA · Cancer Resource Center of the Desert · University of California, San Diego · NCT06664034 A Phase 3 Study to Evaluate the Safety and Efficacy of KarXT + KarX-EC for the Treatment of Agitation Associated With Al Phase 3 · Bristol-Myers Squibb · NCT07011745 Testing the Use of Combination Therapy in Adult Patients With Newly Diagnosed Multiple Myeloma, the EQUATE Trial Phase 3 · ECOG-ACRIN Cancer Research Group · NCT04566328 A Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phase 3 · Hoffmann-La Roche · NCT05894239 LIVERAGE™ - Cirrhosis: A Study to Test Whether Survodutide Helps People With a Liver Disease Called NASH/MASH Who Have C Phase 3 · Boehringer Ingelheim · NCT06632457 A Study to Learn About How 20-Valent Pneumococcal Conjugate Vaccine Works in a Real-world Setting Phase N/A · El Centro Regional Medical Center · Pfizer · NCT05452941 The Vizio Clinical Study NA · Ocumedex · NCT06591117 Randomized Study Using SM-030 Gel for Adults With Melasma Phase 2 · DermBiont, Inc. · NCT06454747 A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirze Phase 2 · Eli Lilly and Company · NCT06897475 A Clinical Trial Investigating the Safety, Tolerability, and Therapeutic Effects of BNT113 in Combination With Pembroliz Phase 2/Phase 3 · BioNTech SE · NCT04534205 Enhancing PrEP Uptake and Retention Among Latine TGW and GBM in the South Using Long-Acting Injectable PrEP Phase 4 · Duke University · NCT07218211 A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of Obinutuzumab in Adolescents With Active Class III or I Phase 2 · Hoffmann-La Roche · NCT05039619
Look up another city
Look up another condition